U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06927076) titled 'Antidepressant Response of DMT Masked With Propofol' on April 04.
Brief Summary: The aim of this study is to elucidate if the anti-depressive effect of N,N-dimethyltryptamine (DMT) is based on a biological mechanisms including neuroplasticity and anti-inflammatory effect or due to the subjective psychedelic experience.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Major Depressive Disorder
Psychedelic Experiences
Intervention:
DRUG: N,N-Dimethyltryptamine
administration of a 2mg/min DMT perfusion over 20 min
DRUG: Placebo
administration of a placebo perfusion over 20 min
PROCEDURE: Propofol
30 min p...